Concord Healthcare Marks Milestone: China’s First Proton Therapy for Choroidal Melanoma Successfully Completed,PR Newswire Healthring
Concord Healthcare Marks Milestone: China’s First Proton Therapy for Choroidal Melanoma Successfully Completed BEIJING, China – July 14, 2025 – Concord Healthcare is proud to announce a significant advancement in ophthalmic oncology within China. The company has successfully completed the nation’s first-ever proton therapy treatment for a patient diagnosed with choroidal malignant melanoma. This groundbreaking … Read more